Double Plasma Molecular Adsorption System as Treatment in A Severe Acute-OnChronic Liver Failure in A Patient with Autoimmune Hepatitis

The use of extracorporeal liver support systems (ECLS) to bridge the patient to liver transplant (LT) or recovery, has been improved in the last years. We present a case of a 55-year female with autoimmune hepatitis who presented liver failure and underwent trough 3 sessions of double plasma molecular adsorption system (DPMAS) as an extracorporeal liver support system. This case illustrates how the use of DPMAS as an ECLD, is safe and effective in reducing bilirubin levels and inflammatory markers in patients with liver failure.